Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Snjezana, Uncanin"'
Autor:
Snjezana Uncanin, Azra Haracić, Jasminka Dzemidzić, Indira Kulenović, Irfan Zulić, Mithat Cengić, Senija Rasić
Publikováno v:
Bosnian Journal of Basic Medical Sciences, Vol 3, Iss 4 (2003)
Anaemia appears to play an important role in left ventricular (LV) enlargement in chronic kidney disease patients. The objective of this study was to evaluate LV echocardiography changes during anaemia correction with recombinant human erythropoietin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4facbb4c017c7aa104cd565b2c8d03b6
https://doi.org/10.17305/bjbms.2003.3485
https://doi.org/10.17305/bjbms.2003.3485
Autor:
Ismar Rašić, Kenana Aganović, Senija Rasić, Snjezana Uncanin, Jasminka Dzemidzić, Alma Muslimović
Publikováno v:
Bosnian Journal of Basic Medical Sciences, Vol 8, Iss 3 (2008)
The aim of this retrospective study was to evaluate the results of the immunosuppressive regiment in managing of IgA nephropathy associated with primary nephrotic syndrome at the Nephrology Clinic, University of Sarajevo Clinics Centre in period of 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25eb9d5cd6cbafe0b0f1d21aff557983
https://europepmc.org/articles/PMC5694673/
https://europepmc.org/articles/PMC5694673/
Publikováno v:
Bosnian Journal of Basic Medical Sciences, Vol 6, Iss 2 (2006)
Bosn J Basic Med Sci
Scopus-Elsevier
Bosn J Basic Med Sci
Scopus-Elsevier
Strict therapy protocol, which would be used universally for certain morphological forms of primary nephrotic syndrome, does not exist. The aim of the study was to show the effects of used therapy protocol in treatment of primary nephrotic syndrome a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a83e94944f6c9042f0a8aa6793b2589
http://www.bjbms.org/ojs/index.php/bjbms/article/view/3166
http://www.bjbms.org/ojs/index.php/bjbms/article/view/3166
Publikováno v:
Medicinski arhiv. 59(4)
Cardiovascular diseases represent the leading cause of mortality in patients with end-stage renal disease treated by hemodialysis. Left ventricular hypertrophy (LVH), which is connected with various risk factors present in this population of patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::349e9230bbeeed3210510b89b68a9352
https://pubmed.ncbi.nlm.nih.gov/16018389
https://pubmed.ncbi.nlm.nih.gov/16018389
Autor:
Senija, Rasić, Amra, Catović, Jasmin, Huskić, Azra, Haracić, Nermina, Babić, Nesina, Avdagić, Snjezana, Uncanin
Publikováno v:
Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti. 58(3)
Anemia has been shown to be a key component of renal failure, as well as of the occurrence of left ventricular hypertrophy (LVH), with special attention paid to the paracrine mechanism of left ventricular remodelling.The aim of the study was to analy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::14984a01828a84cd1eec4fd8fc1839bb
https://pubmed.ncbi.nlm.nih.gov/15503682
https://pubmed.ncbi.nlm.nih.gov/15503682
Autor:
Senija, Rasić, Indira, Kulenović, Irfan, Zulić, Jasminko, Huskić, N, Avdagić, N, Babić, Snjezana, Uncanin, A, Haracić
Publikováno v:
Medicinski arhiv. 58(2)
Left ventricular hypertrophy (LVH) is commonly present in hemodialysis patients (HD pts) and is considered as an independent risk factor for high mortality. Many studies have confirmed sound connection between anemia and LVH in this patients.To analy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1e1e0ac9586147bc705eefa1615ed9f9
https://pubmed.ncbi.nlm.nih.gov/15202319
https://pubmed.ncbi.nlm.nih.gov/15202319